Importantly, CRLF2 rearrangements and JAK2 mutations, collectively leading to increased TSLP-R signaling capacity, have been associated with poor outcomes in patients with Ph-like ALL[88]. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.